Cell and Gene Therapy Tools, and Reagents: Global Markets

Nov 2022| BIO208B| BCC Publishing
Sample Report

Report Highlights

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

Report Includes

  • 105 total tables
  • An updated overview of the global market for immunoassay-based cell and gene therapy tools and reagents
  • Analyses of the global market trends, with historic market revenue for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the market potential for the cell and gene therapy tools and reagents in the life sciences industry, growth driving factors, and areas of focus to forecast this market into various segments and sub-segments
  • Estimation of actual market size and revenue forecast for cell and gene therapy tools and reagents in USD million terms, and corresponding market share analysis based on product, application/disease area, end-user, and region
  • In-depth information (facts and figures) concerning major market dynamics (DROs), product innovations, clinical trials, and various government regulations affecting the market outlook for cell and gene therapy tools and reagents
  • Review of prevalence of infectious disease, metabolic disorders and chronic ailments; along with the recent technological advancements, competitive environment, and the industry value chain analysis
  • Coverage of the technological, economic, and business considerations of the prevailing cell and gene therapy tools market, and its vendor landscape
  • Patent review and new developments, R&D efforts, industrial changes with emphasis on recent investments, and current state of the immunoassay technology
  • Identification of the companies best positioned to meet the demand for cell and gene therapy in life sciences applications owing to their proprietary technologies, novel product launches, key mergers and acquisition deals, and other strategic advantages
  • Descriptive company profiles of the market leading players, including Abcam, Akron Biotech, Adverum Biotechnologies and Avrobio.

Report Scope

The scope of this study encompasses an investigation of cell and gene therapy tools: GMP proteins, media, cell separation and activation reagents, viral and non-viral, cytokine release syndrome monitoring products, GMP antibodies, leukapheresis instrumentation, immunoassays (multiplex and singleplex) and bioreactors. BCC Research analyzes each tool type, determines its current market status, examines its impact on future markets and presents forecasts of growth over the next six years. The current report provides detailed analysis of the market's drivers, challenges and opportunities. The report also covers market projections to 2027 and market share for key market players. The report includes the company profiles of key players with detailed information about business segments, financials, product portfolios and recent developments. The report provides impact analysis of the COVID-19 pandemic on this market.

Frequently Asked Questions (FAQs)

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $7.6 Billion
Market size forecast $13.8 Billion
Growth rate CAGR of 10.6% from 2022 to 2027
Units considered $ Million
Segments covered Type, Disease, End User
Regions covered North America, Europe, Asia Pacific, and Rest of the World (RoW)
Key Market Drivers
  • Increasing investments in CGT R&D
  • Increasing prevalence of chronic diseases
  • Increasing strategic collaborations and acquisitions
  • Increasing capacity expansions and manufacturing capabilities
Companies studied
ABCAM
AKRON BIOTECH
ADVERUM BIOTECHNOLOGIES
ATHERSYS INC.
AVROBIO
BIO-RAD LABORATORIES
BIO-TECHNE
CELLGENIX
CYTIVA LIFE SCIENCES
FUJIFILM IRVINE SCIENTIFIC
LUMINEX CORP.
MESOBLAST LTD.
MERCK KGAA
MILTENYI BIOTEC
ORGANICELL
PROTEINTECH GROUP INC.
SARTORIUS
SINO BIOLOGICAL INC.
STEMCELL TECHNOLOGIES
THERMO FISHER SCIENTIFIC

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesPrice Member Price
Full Report: Cell and Gene Therapy Tools, and Reagents: Global Markets139 $5,500 Free
Chapter- 1: Introduction7Free DownloadFree
Chapter- 2: Summary and Highlights3$250Free
Chapter- 3: Market and Technology Background6$237Free
Chapter- 4: Market Dynamics8$317Free
Chapter- 5: Market Breakdown, by Application7$277Free
Chapter- 6: Market Breakdown, by End User8$317Free
Chapter- 7: Market Breakdown, by Type60$2,374Free
Chapter- 8: Market Breakdown by Region5$198Free
Chapter- 9: Government Regulations3$119Free
Chapter- 10: Patent Review/New Developments5$198Free
Chapter- 11: Competitive Landscape3$119Free
Chapter- 12: Company Profiles24$950Free
Published - Aug-2020| Analyst - Todd Graham| Code - BIO208A

Report Highlights

The global market for life science tools should grow from $6.5 billion in 2019 to reach $9.0 billion by 2024 at a compound annual growth rate (CAGR) of 8.5% during the forecast period of 2019-2024.

Report Includes

  • 77 data tables
  • An overview of the global market for immunoassay-based cell and gene therapy tools, and reagents within the life sciences industry
  • Analyses of the global market trends, with data corresponding to market size for 2017-2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Information about in vitro diagnostics (IVD), its background and importance of IVD testing
  • Discussion on prevalence of infectious disease, metabolic disorders and chronic ailments as drivers of immunoassay testing market
  • Description of recent technologies such as chemiluminescent immunoassays (CLIA), fluorescent immunoassays, multiplex assays and rapid diagnostic technologies
  • Evaluation of market potential for immunoassay-based cell and gene therapy tools and reagents, current market size and market forecast, and market share analysis of the leading players engaged
  • Patent review and new developments, R&D efforts, industrial changes with emphasis on recent investments, and current state of the immunoassay technology
  • Company profiles of the key market participants, including Bio-Rad Laboratories, Cytiva Life Sciences, Luminex Corp., Millipore Sigma, Thermo Fisher Scientific and STEMCELL Technologies
Cell and Gene Therapy Tools, and Reagents: Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS